Q2 2024 · 13F-HR
Mayo Clinicholdings as filed
Filed 2024-08-12 · accession 0000950123-24-007732
$3.0M
Reported value
4
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 464288257 | ACWI | MSCI ACWI ETF | $2.0M | 64.4% | 17,359 | Common | SOLE |
| 98943L107 | ZNTL | Zentalis Pharmaceuticals Inc. | $765,415 | 25.3% | 187,143 | Common | SOLE |
| 91381U200 | UNBX | UNITY BIOTECHNOLOGY INC | $167,509 | 5.53% | 124,081 | Common | SOLE |
| 64130M209 | — | Neuroone Medical Technologies | $145,403 | 4.80% | 181,754 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.